間充質(zhì)干細(xì)胞向神經(jīng)細(xì)胞分化的Tau蛋白表達(dá)
[Abstract]:Background & objective Bone marrow derived mesenchymal stem cells (Mesenchymal stem cells,MSCs) are another kind of stem cells which exist in bone marrow except hematopoietic stem cells (hemopoietic stem cells,HSCs). They are early cells of mesoderm development. It is not only involved in the production of hematopoietic microenvironment to support hematopoiesis, but also can differentiate into mesoderm and neuroectodermal tissue cells: osteoblasts, adipocytes, nerve cells, hepatocytes, endothelial cells and so on. Because of its high self-renewal ability and multi-directional differentiation potential, it is an ideal cell source for cell replacement therapy and gene therapy. At present, the research focus of MSCs is to find highly specific methods of isolation and purification, transplantation to treat dysfunction of various systems and reconstruction of tissue function, research on telomerase activity, target cells for gene therapy, and comparative study with MAPCs, and so on. For the study of MSCs-induced differentiation into nerve cells, the detection of neuron-specific markers and the assessment of behavior after transplantation of MSCs animal model are more important. Tau protein, is the highest content of neuronal microtubule-associated protein (microtubule associated protein,MAPs). The main function of Tau protein is to promote the formation of microtubule and maintain the stability of microtubule, reduce the dissociation of microtubule protein, and induce microtubule bundle formation. Tau protein is still in the differentiation of neurons, and the main function of tau protein is to promote the formation of microtubule and maintain the stability of microtubule. Tau protein plays an important role in the process of maturation endocrine activity and receptor activation. Tau protein can regulate the assembly of microtubule in time and space through its phosphorylation state. Abnormal phosphorylation of Tau protein can cause dysfunction of neural cells and loss of normal physiological function, leading to the occurrence of nervous system diseases (such as Alzheimer's disease). The accurate induction and differentiation of MSCs is the basis of its application in clinical treatment, which requires in-depth study on the signal regulation and microenvironmental effects of MSCs development. At present, it has been found that in vitro MSCs
【學(xué)位授予單位】:鄭州大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2005
【分類號(hào)】:R329
【參考文獻(xiàn)】
相關(guān)期刊論文 前8條
1 胡以平;干細(xì)胞:生物醫(yī)藥研究的新靶標(biāo)[J];第二軍醫(yī)大學(xué)學(xué)報(bào);2002年11期
2 王磊,袁錦楣,郝洪軍,李海峰,金弘敏,冀成君;阿爾茨海默病患者腦脊液中Tau蛋白的含量及意義[J];中國(guó)臨床神經(jīng)科學(xué);2000年04期
3 王亭忠,馬愛群;干細(xì)胞分化及其調(diào)控機(jī)制研究進(jìn)展[J];心臟雜志;2004年05期
4 陳運(yùn)賢,歐瑞明,鐘雪云,鐘立業(yè),陳惠珍,彭龍?jiān)?曾武濤,靳三慶,張希,韓忠朝;粒細(xì)胞集落刺激因子動(dòng)員骨髓干細(xì)胞治療大鼠急性心肌梗塞[J];中國(guó)病理生理雜志;2002年01期
5 張麗蓉,項(xiàng)鵬,夏文杰,陳振光,張秀明,李艷,李樹濃;PD98059對(duì)人骨髓間質(zhì)干細(xì)胞分化為成骨細(xì)胞的影響[J];中國(guó)病理生理雜志;2002年08期
6 肖慶忠,李浩威,溫冠媚,黃少華,張秀明,李艷,李樹濃;麝香多肽體外誘導(dǎo)成年大鼠和人骨髓間充質(zhì)干細(xì)胞定向分化為神經(jīng)元的研究[J];中國(guó)病理生理雜志;2002年10期
7 宮立眾,孫士紅,程天民,粟永萍,羅成基,郭朝華;骨髓間質(zhì)干細(xì)胞輸注對(duì)外周血干細(xì)胞移植造血恢復(fù)的影響[J];中國(guó)病理生理雜志;2002年11期
8 陳運(yùn)賢,鐘雪云,歐瑞明;造血干細(xì)胞的可塑性及臨床應(yīng)用[J];中國(guó)病理生理雜志;2002年12期
,本文編號(hào):2436926
本文鏈接:http://sikaile.net/yixuelunwen/binglixuelunwen/2436926.html